Development of a latex particles-based lateral flow immunoassay for group determination of macrolide antibiotics in breast milk

J Pharm Biomed Anal. 2020 Sep 10:189:113450. doi: 10.1016/j.jpba.2020.113450. Epub 2020 Jul 13.

Abstract

A lateral flow immunoassay (LFIA) using latex particles labeled with antibody to BSA-clarithromycin (CLA) was developed for the rapid simultaneous group determination of six macrolide antibiotics. Optimization of antigen spotting on the membrane and latex probe loading allowed improving visual detectability (vLOD) 100 times, which was 1, 1, 10, 10, 50, and 1000 ng/mL for CLA, roxithromycin, erythromycin, dirithromycin, azithromycin, and oleandomycin in buffer, respectively. The calculated limits of instrumental detection (cLOD) were respectively 0.12, 0.15, 1.4, 2.1, 2.4, and 3.3 ng/mL. To avoid a strong influence of breast milk of a very diverse and variable composition, a sample pretreatment is proposed. The six macrolides mentioned can be visually detected in breast milk after 20 min pretreatment at concentrations of 10-1000 ng/mL or instrumentally with cLOD of 4.0, 2.5, 30, 42, 42 and 180 ng/mL. The recovery rate from the spiked samples carried out using a strip scanner device ranged from 71 % to 110 %, and precision expressed as relative standard deviation was between 3-14 %. The described rapid on-site diagnostic assay format can be useful for monitoring the content of antibiotics in breast milk during macrolide treatment to ensure safe breastfeeding of infants.

Keywords: Azithromycin; Clarithromycin; Dirithromycin; Erythromycin; Group-specificity; Lateral flow immunoassay; Oleandomycin; Roxithromycin.

MeSH terms

  • Anti-Bacterial Agents / analysis
  • Clarithromycin / analysis
  • Humans
  • Immunoassay
  • Macrolides*
  • Microspheres
  • Milk, Human* / chemistry

Substances

  • Anti-Bacterial Agents
  • Macrolides
  • Clarithromycin